Bringing stakeholders together is the mission of AJMCLive, the meeting series of The American Journal of Managed Care. It's reflected in the two keynote speakers for Patient-Centered Oncology Care on Nov. 14: a leader of physicians, Peter Yu, MD, the current president of ASCO; and a leader among payers, Burton VanderLaan, MD, FACP, medical director of Priority Health.
PLAINSBORO, N.J. — Peter P. Yu, MD, FASCO, the current president of the American Society of Clinical Oncology; and Burton VanderLann, MD, FACP, medical director for Priority Health, will be keynote addresses Nov. 14, 2014, at Patient-Centered Oncology Care, the upcoming AJMCLive event in Baltimore, Md.
For agenda information and to register for the event, which begins Nov. 13, 2014, click here.
The selection of Drs. Yu and VanderLaan reflects the mission of The American Journal of Managed Care in its AJMCLive series, which aims to bring together stakeholders from across the healthcare spectrum: providers, payers, policymakers and pharmaceutical company leaders come together to share ideas and network. Patient-Centered Oncology Care, which will be in its third year, will explore the challenges in cancer care as those who deliver care and those who pay for it seeks to define “value” as the cost of cancer therapy soars.
“Having two well-known keynote speakers offering different viewpoints embodies our goal: to create the settings where problem-solving occurs,” said Brian Haug, publisher of The American Journal of Managed Care. “This is a must-attend event for health insurance decision-makers, in oncology, for Medicare or Medicaid officials, or large employers with self-funded health plans.”
Peter P. Yu, MD, FASCO, a medical oncologist and hematologist, is the Director of Cancer Research at Palo Alto Medical Foundation, where he worked since 1989. Dr. Yu received his medical degree from Brown University, and performed his internship and residency in Internal Medicine at St. Luke’s-Roosevelt Hospital and a fellowship in neoplastic diseases at Mount Sinai Hospital. He was a research fellow and associate at Memorial Sloan Kettering Cancer Center.
Dr. Yu spoke to the need to bring different perspectives together in a recent interview. “If we are going to make progress in improving and designing a healthcare system that is sustainable, we need to engage all the stakeholders in the system,” he said.
Burton VanderLaan, MD, FACP, is medical director for Network Effectiveness at Priority Health. Dr. VanderLaan is responsible for improved performance of the networks and delivery systems. His focus is on successful development and implementation of medical management programs in partnership with the organization's network of physicians and hospitals. Prior to joining Priority Health, he served as regional medical director for Aetna, Inc. for the Midwestern area.
About the Journal
The American Journal of Managed Care, now in its 20th year of publication, is the leading peer-reviewed journal dedicated to issues in managed care. Other titles in the AJMC family of publications are The American Journal of Pharmacy Benefits, which provides pharmacy and formulary decision makers with information to improve the efficiency and health outcomes in managing pharmaceutical care. In December 2013, AJMC introduced The American Journal of Accountable Care, which publishes research and commentary devoted to understanding changes to the healthcare system due to the 2010 Affordable Care Act. AJMC’s news publications, the Evidence-Based series, bring together stakeholder views from payers, providers, policymakers and pharmaceutical leaders in the areas of oncology, diabetes management, and immunology and infectious disease. To order reprints of articles appearing in AJMC publications, please call (609) 716-7777, x 131.
CONTACT: Nicole Beagin (609) 716-7777 x 131
Exploring Racial, Ethnic Disparities in Cancer Care Prior Authorization Decisions
October 24th 2024On this episode of Managed Care Cast, we're talking with the author of a study published in the October 2024 issue of The American Journal of Managed Care® that explored prior authorization decisions in cancer care by race and ethnicity for commercially insured patients.
Listen
Uniting to Support Patients With Cancer Beyond Treatment
November 17th 2024Kasey Bond, MPH, of Perlmutter Cancer Center at NYU Langone Health, speaks to why it’s vital to keep patients at the center of all strategic partnerships between academic institutions and community-based oncology practices.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Bridging Cancer Care Gaps and Overcoming Medical Mistrust
November 13th 2024In this clip from our interview with Oscar B. Lahoud, MD, cochair of our Institute for Value-Based Medicine® evening hosted with NYU Langone Health, he addressed medical mistrust in underrepresented communities.
Read More
How English- and Spanish-Preferring Patients With Cancer Decide on Emergency Care
November 13th 2024Care delivery innovations to help patients with cancer avoid emergency department visits are underused. The authors interviewed English- and Spanish-preferring patients at 2 diverse health systems to understand why.
Read More